Atlas Trials

Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults

Clinical trial NCT00819013 · COMPLETED

Trial details

NCT number
NCT00819013
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza
Start date
2007-07-01
Primary completion
2009-01-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.